Ellen H.M. Moors
机构: Professor Sustainable Innovation
每年引用次数
引用次数
引用: 4,473
H-指数: 36
I10-指数 : 69
出版物: 199
STAKEHOLDER ENGAGEMENT IN PHARMACEUTICAL REGULATION: CONNECTING TECHNICAL EXPERTISE AND LAY KNOWLEDGE IN RISK MONITORING
ALBERT MEIJER , WOUTER BOON , ELLEN MOORS
Public Administration 91 ( 3) 696 -711
14
2013
EMERGING TECHNOLOGIES FOR DIAGNOSING ALZHEIMER’S DISEASE
EDITED BY MARIANNE BOENINK , HARRO VAN LENTE , ELLEN MOORS
The value of non-human primates in the development of monoclonal antibodies
E H M Moors , H Schellekens , P J K van Meer , M Kooijman
Nature Biotechnology 31 ( 10) 882 -883
26
2013
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in Europe.
Wouter PC Boon , Ellen HM Moors , A Meijer , Huub Schellekens
Clinical Pharmacology & Therapeutics 88 ( 6) 848 -853
42
2010
Interactive Communication in Pharmacogenomics Innovations: User-producer interaction from an innovation and science communication perspective
R. P. Verhoeff , E. H. M. Moors , P. Osseweijer
Life Sciences, Society and Policy 4 ( 2) 53 -69
3
2008
TECHNOLOGY CHOICES FOR SUSTAINABLE INDUSTRIAL PRODUCTION: TRANSITIONS IN METAL MAKING
ELLEN H.M. MOORS , PHILIP J. VERGRAGT
International Journal of Innovation Management 06 ( 03) 277 -299
15
2002
User-Producer Interactions in Emerging Pharmaceutical and Food Innovations
Ellen HM Moors , WPC Boon , Roel Nahuis , RLJ Vandeberg
International Journal of Innovation Management 12 ( 3) 161 -188
29
2008
R&D COLLABORATION IN THE LIFE SCIENCES: FINDING PARTNERS AND THE ROLE OF RESOURCE-BASED INDUCEMENTS AND OPPORTUNITIES
T. VAN DER VALK , M. T. H. MEEUS , E. H. M. MOORS , J. FABER
International Journal of Innovation Management 14 ( 02) 179 -199
6
2010
Does market exclusivity hinder the development of Follow-on Orphan Medicinal Products in Europe?
Anne EM Brabers , Ellen HM Moors , Sonja van Weely , Remco LA de Vrueh
Orphanet Journal of Rare Diseases 6 ( 1) 59 -59
9
2011
Pathways in the Drug Development for Alzheimer’s Disease (1906-2016): A Bibliometric Study
Isabel Schilder , Désirée H Veening-Griffioen , Guilherme S Ferreira , Peter JK Van Meer
Journal of Scientific Research 9 ( 3) 277 -292
4
2020
Implementation of magnetic resonance imaging-guided radiation therapy in routine Care: Opportunities and challenges in the United States
Charisma Hehakaya , Ankur M Sharma , Jochem RN van der Voort Van , Diederick E Grobbee
Advances in Radiation Oncology 7 ( 5) 100953 -100953
14
2022
177 Lu-PSMA for advanced prostate cancer: are we ready to play big?
Charisma Hehakaya , Ellen HM Moors , Helena M Verkooijen , Diederick E Grobbee
European Journal of Nuclear Medicine and Molecular Imaging 48 2325 -2328
4
2021
Does regional proximity still matter in a global economy? The case of flemish biotech ventures
JL Taks , Andrea M Herrmann , Ellen HM Moors
Frontiers of Entrepreneurship Research 31 ( 16) 517 -529
1
2012
Science, technology, and innovation for sustainable development goals: insights from agriculture, health, environment, and energy
Ademola A Adenle , Marian R Chertow , Ellen HM Moors , David J Pannell
Oxford University Press
20
2020
Dynamics of sociotechnical change in transport and mobility-opportunities for governance
Ellen HM Moors , Frank W Geels
Global Change NOP-NRP report 410200071
3
2001
Market formation in a global health transition
Freek de Haan , Ellen HM Moors , Arjen M Dondorp , Wouter PC Boon
Environmental innovation and societal transitions 40 40 -59
15
2021
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
Freek De Haan , Oladimeji Akeem Bolarinwa , Rosemonde Guissou , Fatoumata Tou
PLoS One 16 ( 8) e0256567 -e0256567
7
2021
The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
Rosemonde M Guissou , Chanaki Amaratunga , Freek De Haan , Fatoumata Tou
Malaria journal 22 ( 1) 269 -269
3
2023
Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion
Freek de Haan , Chanaki Amaratunga , Van Anh Cao Thi , Long Heng Orng
Malaria journal 22 ( 1) 261 -261
1
2023
Ethical, regulatory and market related aspects of deploying triple artemisinin-based combination therapies for malaria treatment in Africa
Oladimeji Akeem Bolarinwa , Olugbenga Ayodeji Mokuolu , Rosemonde Guissou , Fatoumata Tou
The Global Health Network Collections
1
2023